Cardiac Rhythm Simulator

Low QRS Voltage

LVQRSAL Condition

Last updated

Clinical Overview

Low QRS voltage is an ECG amplitude finding, not a rhythm or a single disease — it describes an abnormally small QRS complex on the surface electrocardiogram, most often because something between the heart and the recording electrodes is attenuating its electrical signal, or because the heart itself is generating a weaker signal than normal. The standard diagnostic criterion is met when either the peak-to-trough QRS amplitude is under 5 mm (0.5 mV) in every limb lead, or under 10 mm (1.0 mV) in every precordial lead — the two criteria are evaluated independently, and a tracing can satisfy one without the other. This dataset’s own label, “Lower Voltage QRS In All Lead,” literally suggests a single uniform reduction across every lead, while the standard clinical criteria are an either/or test against two separate lead groups; it is not confirmed here whether this dataset’s own annotation logic requires both groups to be affected simultaneously or applies the standard either/or rule — neither the original Zheng et al. dataset paper nor PhysioNet’s own database documentation describes per-label annotation criteria, so this remains an open question about this dataset’s internal methodology rather than one resolvable from any public source. A SNOMED-mapping review confirmed that this dataset’s underlying code for the label resolves to the correct “Low QRS voltages” concept, so the code itself is not in question — only the historical dataset label’s wording.

Mechanistically, the causes fall into three broad categories. The first is signal damping: something with poor electrical conductivity sits between the heart and the skin, insulating the true cardiac signal — excess fluid (pericardial or pleural effusion), fat (obesity), or air (emphysema, pneumothorax, pneumomediastinum) all increase the effective distance and impedance between the heart and the electrode. The second is loss of viable myocardium: after an extensive prior myocardial infarction, the scarred tissue can no longer generate normal depolarization forces, so less net voltage reaches the surface. The third is diffuse infiltration of the myocardium itself, most classically by amyloid protein, but also myxedema (severe hypothyroidism), sarcoidosis, and hemochromatosis, all of which replace or stiffen contractile tissue and blunt its electrical output.

Clinically, the most urgent scenario is new-onset low voltage accompanied by tachycardia and electrical alternans (a beat-to-beat alternation in QRS amplitude or axis) — this triad classically signals a large pericardial effusion with impending or actual cardiac tamponade and warrants immediate evaluation. Away from that acute picture, low voltage is frequently a chronic, low-urgency finding explained by a patient’s known body habitus (obesity) or lung disease (COPD). A separate and clinically important pattern occurs in cardiac amyloidosis: low QRS voltage has been reported in roughly 41% of cardiac amyloidosis patients overall, and is more common in the AL (light-chain) type — around 55% — than in the ATTR (transthyretin) type, around 33-35% (Cipriani et al., JACC: CardioOncology, 2022, n=411); a second, independent cohort study corroborates both the direction and magnitude of this AL-versus-ATTR gap (Argirò et al., ESC Heart Failure, 2025). When this low voltage coexists with an echocardiogram showing thickened, hypertrophied ventricular walls — a mismatch sometimes called “paradoxical left ventricular hypertrophy” or a voltage-to-mass mismatch — it is a recognized diagnostic clue that should raise suspicion for an infiltrative cardiomyopathy such as amyloidosis rather than being dismissed as isolated low voltage or attributed to ordinary hypertensive hypertrophy.

Low QRS voltage is not itself symptom-producing; any symptoms trace back to whatever is causing it. A patient with chronic, stable low voltage from obesity or COPD is typically asymptomatic from a cardiac standpoint. A patient with a large pericardial effusion may report dyspnea, chest fullness or pressure, and can present in extremis with hypotension and tachycardia if tamponade develops. A patient with underlying hypothyroidism most commonly reports fatigue or generalized weakness and dyspnea, alongside the bradycardia that often accompanies the low-voltage finding on the same tracing. A patient with cardiac amyloidosis typically presents with the symptoms of diastolic heart failure — exertional dyspnea, fatigue, and fluid retention — rather than any symptom referable to the ECG finding itself.

Causes and risk factors include: pericardial effusion or pleural effusion (fluid insulation); obesity (fat insulation); COPD, emphysema, or pneumothorax (air insulation); extensive prior myocardial infarction (loss of viable myocardium); cardiac amyloidosis, both AL and ATTR subtypes (myocardial infiltration); hypothyroidism/myxedema; and, less commonly, sarcoidosis, hemochromatosis, and acute myocarditis. Occasionally low voltage has no identifiable cause and is treated as a normal variant.

Interpretation Guide

Key Features:

  • Rate: not a defining feature — low voltage is an amplitude finding superimposed on whatever rate the underlying rhythm happens to show, though bradycardia is common when hypothyroidism is the cause
  • Rhythm: not a defining feature — this finding can accompany any underlying rhythm
  • P waves: not part of the diagnostic criteria, but P-wave amplitude is often reduced alongside the QRS when a diffuse insulating or infiltrative process is present
  • PR interval: usually within normal limits; hypothyroidism-associated cases can show a prolonged PR interval or first-degree AV block
  • QRS complex: the defining feature — peak-to-trough QRS amplitude under 5 mm (0.5 mV) in every limb lead, or under 10 mm (1.0 mV) in every precordial lead; either criterion alone is sufficient, and some tracings show it in the limb leads only, with normal-amplitude precordial complexes
  • ST segment: usually unremarkable from the low-voltage finding alone; diffuse, nonspecific ST-segment changes can accompany a pericardial or myxedema-related cause
  • T waves: usually normal from this finding alone; widespread T-wave flattening or inversion is part of the separate three-finding hypothyroidism/myxedema pattern (alongside bradycardia and low voltage) when that is the underlying cause
  • QT interval: not independently affected by low voltage itself; a prolonged QTc has been reported in hypothyroidism-associated cases
  • Other findings: electrical alternans occurring together with tachycardia and low voltage is the classic triad of a large pericardial effusion with possible tamponade and warrants urgent evaluation

Key Leads

  • No single lead defines this finding — the diagnostic criteria are evaluated separately across two lead groups, and a tracing can meet either one independently of the other.
  • Leads I, II, III, aVR, aVL, aVF (the limb leads) – peak-to-trough QRS amplitude under 5 mm (0.5 mV) in every lead in this group defines the limb-lead low-voltage criterion; can occur with normal-amplitude precordial leads.
  • Leads V1-V6 (the precordial leads) – peak-to-trough QRS amplitude under 10 mm (1.0 mV) in every lead in this group defines the precordial low-voltage criterion, met independently of the limb-lead group.

Differential Diagnosis

  • Left Ventricle Hypertrophy (LVH) — classic LVH increases, rather than decreases, QRS voltage; when an echocardiogram shows thickened ventricular walls but the ECG shows genuinely low voltage instead of the expected high-voltage hypertrophy pattern, that “paradoxical” mismatch points toward an infiltrative cardiomyopathy such as amyloidosis rather than true electrical hypertrophy
  • R Wave Abnormal (RWAb) — abnormal or poor R-wave progression is typically a regional, precordial-lead-specific pattern (for example, across the anterior leads) rather than the diffuse amplitude reduction spanning an entire limb- or precordial-lead group that defines low voltage
  • Abnormal Q Wave / Pathologic Q Wave (AQW) — extensive myocardial infarction can regionally reduce QRS amplitude through cancellation of electrical forces, but this is accompanied by pathological Q waves confined to the infarct-related leads rather than a diffuse reduction meeting the limb- or precordial-lead voltage criteria
  • Anterior Myocardial Infarction (AnMI) — a similar regional-amplitude-loss mechanism, but localized to the anterior precordial leads with a supporting Q-wave or ST-segment pattern and an ischemic clinical picture, rather than the global amplitude reduction low voltage describes

Treatment Brief

Low voltage itself is an ECG finding, not a diagnosis to treat directly — the appropriate response depends entirely on identifying and addressing the underlying cause.

  • New-onset low voltage, especially together with tachycardia or electrical alternans, warrants prompt provider notification and evaluation for a large pericardial effusion or tamponade, typically with bedside echocardiography.
  • Compare against a prior ECG when one is available — chronic, stable low voltage in a patient with known obesity, COPD, or a prior large myocardial infarction is far less concerning than a new finding in a previously normal tracing.
  • When low voltage coexists with echocardiographic evidence of thickened ventricular walls, flag the mismatch for an amyloidosis workup rather than assuming ordinary hypertensive or hypertrophic cardiomyopathy.
  • If bradycardia and widespread T-wave changes accompany the low voltage, consider hypothyroidism and correlate with thyroid function testing and the patient’s clinical picture.
  • Confirm lead placement and repeat the tracing if the finding is new or unexpected, since technical factors can occasionally mimic true low voltage.

ECG examples

Open in Explorer Practice rhythm identification